Complement-Binding Anti-HLA Antibodies and Kidney-Allograft Survival
Alexandre Loupy(Hôpital Necker-Enfants Malades), Xavier Jouven(San Diego Cardiac Center)
Cited by 826
Related Papers
Banff 2013 Meeting Report: Inclusion of C4d-Negative Antibody-Mediated Rejection and Antibody-Associated Arterial Lesions
|American Journal of Transplantation|2014|1.3k
The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell–mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials
|American Journal of Transplantation|2017|1k
The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell– and antibody-mediated rejection
|American Journal of Transplantation|2020|809
Out-of-hospital cardiac arrest during the COVID-19 pandemic in Paris, France: a population-based, observational study
|The Lancet Public Health|2020|630
The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology
|American Journal of Transplantation|2016|625